1[1]Yonernura Y, Fujimura T, Nishimura G, et al. Effect of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination [J ]. Surgery, 1996; 119 (4):437-444.
3[3]Gaeber TG, Osmanian C, Jacks T, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumour[ J ]. Nature, 1996; 379: 88-91.
4[4]PH Sugarbaker(ed. ). Peritoneal carcinomatosis:principles of management [ M ]. Kluwer Academic Publishers, Boston,1996: 53-64.
5[5]Allum WH, Hallissey MT, Kelly K. Adjuvant chemotherapy in operable gastric cancer[ J ]. Lancet, March, 1989; 571-574.
6[6]Hamazoe R. Experimental studies on continuous hyperthermic perfusion in the treatment for peritoneal metastases of cancer[J]. Nippon Geka Gakkai Zasshi, 1983 ;84(11): 1117-1129.
7[7]Hamazoe R, Maeta M, Kaibara, et al. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer[J ]. Cancer, 1994,73(8) :2048-2052.
8[8]Fujimura T, Yonemura Y, Muraoka, et al. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study[J]. World J Surg, 1994; 18(1): 150-155.
9[9]Los G, van Vugt M JH, Pinedo MH: Response of peritoneal solid tumors after intraperitoneal chemohyperthermic treatment with cisplatin or carboplatin[J]. Br J Cancer, 1994;69:235-241.
10[10]Hettinga JVE, lemstra W, Meijer C, et al. Mechanism of hyperthermic potentiation of cisplatin action in cisplatinsensitive and resistant tumor cells[J]. Br J Cancer, 1997;75:1735-1743.
